Why, Where and How? CPP Investments' Heather Tobin on Building One of the World's Largest Hedge Fund Portfolios

Why, Where and How? CPP Investments' Heather ...

Up next

How Can We Educate Our Children Better As the World of AI Envelops Us? Peter Frankopan in Conversation With Sir Anthony Seldon

We are releasing as episodes, two panels from the recent Money Maze Allocator Summit. This, the second invitation-only event we have held, gathered some of the world's most significant allocators at the London Stock Exchange for two days of intense discussions and debates. The ag ...  Show more

The Black Box Dilemma: Who Controls What AI Can Say? With CTGT’s Founder & CEO, Cyril Gorlla.

If you are a West Coast based tech start-up, profiled in the Wall Street Journal, Forbes, and Business Insider, are asked to present at JPMorgan's Investor Summit alongside Jamie Dimon, are backed by Google's AI fund, and have a mission to help organizations detect and correct bi ...  Show more

Recommended Episodes

If You Have Money in the Market, Stay with the Market (Podcast)
The Tape

On today’s show we have Janet Lorin, Bloomberg Endowments Reporter, on the latest on the college scandal bribes.  Also joining is Ben Emons, Managing Director: Global Macro Strategy at Medley Global Advisors and a Bloomberg Opinion columnist, on the bond market, European assets, ...  Show more

Investment Masterclass with fund manager Baillie Gifford
Money Clinic with Claer Barrett

Have you ever wondered what it would be like to manage an investment portfolio worth hundreds of billions of pounds? Global equities specialist Malcolm MacColl is one of two managing partners at the helm of Baillie Gifford, the Scottish asset management company, which manages mor ...  Show more

Leading with science: A deep dive on biotech
Center For Investment Excellence

In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ...  Show more